Form 8-K - Current report:
SEC Accession No. 0001640334-20-003199
Filing Date
2020-12-31
Accepted
2020-12-31 17:07:50
Documents
32
Period of Report
2020-12-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm 8-K 16594
2 EX-99.1 lxrp_ex991.htm EX-99.1 42746
3 lxrp_ex991img1.jpg GRAPHIC 51745
4 lxrp_ex991img10.jpg GRAPHIC 73619
5 lxrp_ex991img11.jpg GRAPHIC 61756
6 lxrp_ex991img12.jpg GRAPHIC 51996
7 lxrp_ex991img13.jpg GRAPHIC 59664
8 lxrp_ex991img14.jpg GRAPHIC 66544
9 lxrp_ex991img15.jpg GRAPHIC 72349
10 lxrp_ex991img16.jpg GRAPHIC 64211
11 lxrp_ex991img17.jpg GRAPHIC 82205
12 lxrp_ex991img18.jpg GRAPHIC 53871
13 lxrp_ex991img19.jpg GRAPHIC 81499
14 lxrp_ex991img20.jpg GRAPHIC 71430
15 lxrp_ex991img21.jpg GRAPHIC 51917
16 lxrp_ex991img22.jpg GRAPHIC 46378
17 lxrp_ex991img23.jpg GRAPHIC 45565
18 lxrp_ex991img24.jpg GRAPHIC 38256
19 lxrp_ex991img25.jpg GRAPHIC 51880
20 lxrp_ex991img26.jpg GRAPHIC 54199
21 lxrp_ex991img27.jpg GRAPHIC 42114
22 lxrp_ex991img28.jpg GRAPHIC 42384
23 lxrp_ex991img29.jpg GRAPHIC 57070
24 lxrp_ex991img3.jpg GRAPHIC 90024
25 lxrp_ex991img30.jpg GRAPHIC 40335
26 lxrp_ex991img31.jpg GRAPHIC 155100
27 lxrp_ex991img4.jpg GRAPHIC 72309
28 lxrp_ex991img5.jpg GRAPHIC 52979
29 lxrp_ex991img6.jpg GRAPHIC 63260
30 lxrp_ex991img7.jpg GRAPHIC 61094
31 lxrp_ex991img8.jpg GRAPHIC 50566
32 lxrp_ex991img9.jpg GRAPHIC 37052
  Complete submission text file 0001640334-20-003199.txt   2603066
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52138 | Film No.: 201429389
SIC: 2834 Pharmaceutical Preparations